News Related to Rosalind and Morris Goodman Cancer Institute

Related coverage linked through entity extraction aliases.

Three Research Teams Advance Nanoparticle Platforms for Targeted Cancer Therapy

Mar 08, 2026

Scientists at three institutions have developed distinct nanoparticle-based drug delivery systems designed to target cancer tumors more precisely while reducing side effects, with approaches ranging from DNA nanomachines to transformable nanofibers.

CAR-T Therapy Advances and Nanoparticle Immunotherapy Show Promise in Cancer Treatment

Feb 15, 2026

CAR-T cell therapy engineering advances at Tandem 2026 focus on reducing toxicity and improving access, while McGill researchers develop targeted nanoparticle immunotherapy for lymph node metastases with fewer side effects.